Yuchen Guo
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
tRF-34-P4R8YP9LON4VHM may serve as a promising potential diagnostic biomarker for hepatocellular carcinoma.
Journal: Scientific reports
Published: February 24, 2026
PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 15, 2025
Highly Strong and Tough Supramolecular Polymer Networks Enabled by Cryptand-Based Host-Guest Recognition.
Journal: Angewandte Chemie (International ed. in English)
Published: February 15, 2023
A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer.
Journal: Cancer biology & medicine
Published: October 28, 2021
Mapping the landscape of synthetic lethal interactions in liver cancer.
Journal: Theranostics
Published: June 01, 2021
EGFR activation limits the response of liver cancer to lenvatinib.
Journal: Nature
Published: May 08, 2020
Large scale screening of genetic interaction with sgf73(+) in fission yeast.
Journal: Yi chuan = Hereditas
Published: July 31, 2014
Septin ring assembly is regulated by Spt20, a structural subunit of the SAGA complex.
Journal: Journal of cell science
Published: July 13, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026